Videos

If you get a glioblastoma, you usually only have about 15 months to live.This malignant tumour spreads rapidly through the brain and unfortunately cannot be cured. Yanti De Visser is working on a personalised treatment to already slow down the brain tumour - with success. "The first results show that our approach has the potential to extend patients' lives by years, rather than months," she says.

Every 3 minutes, a woman dies of ovarian cancer somewhere in the world. "Ovarian cancer is very sneaky. Most of the patients respond positively to the therapies initially provided to them, but eventually, the cancer comes back and is much more aggressive. As a result one in two ovarian cancer patients die within 5 years after diagnosis." But what if we were able to treat ovarian cancer with a new therapy using our cells?

Thanks to advanced proton therapy, doctors can precisely start irradiating brain tumours. Unfortunately, they do not yet dare to use this technique on tumours in the belly. Why? Because it's a bit like playing darts with a blindfold, while you have to hit a moving target, as Sophie Heymans explains in this video. She tells you about the technique she is working on to help doctors face this challenge.

Up to 25% of the cells present in lung cancer tumours are currently ignored. As such, we don't know what the role of these so-called B cells is. "It is crucial to figure that out because we cannot efficiently fight something we do not fully understand," says Pauline Bardet (VUB - VIB - FWO).

In her PhD, she wants to get to the bottom of those B cells and thus find out whether those cells are "good guys" or "bad guys".

When removing a kidney tumor, a surgeon has just 20 minutes to do the job. During the operation, the surgeon has to cut off the blood supply to the kidney to avoid a true blood bath. But if the kidney is without blood for too long, too much of it will die off, causing the kidney to malfunction. Using mathematical models, Saar Vermijs aims to help surgeons in their race against the clock...

Today, we can treat cancer better than ever. Yet some cancer types remain very difficult to fight. Such is the case of glioblastoma, a highly aggressive brain cancer in which only 7 in 100 patients are still alive five years after diagnosis. Hoping to help glioblastoma get small, Joke Deschildre doctored a sophisticated strategy to attack cancer cells.

Over the past five years, solid progress has been made in the fight against cancer, but unfortunately, that does not apply to pancreatic cancer. So what makes this cancer so hard to beat? Olaya Lara (VUB) explains this by comparing it to a football match. She also tells you what tactics she figures out to sideline xCT, the Lionel Messi in the pancreatic cancer team. 

Anyone who has ever looked for Waldo knows how hard he is to find. In her research on lung cancer, Rebekka Van Hoof (Uhasselt - KU Leuven - VITO) faces a similar task: she is searching within more than 100,000 so-called extracellular vesicles for 2 types -say 'Waldos'- that can help detect the disease early. But she is determined to narrow her search field. How? Watch her explain it in this video. 

Cancer is a sneaky disease. For instance, cancer cells sometimes manage to disguise themselves, outrunning our immune system. Gils Roex (UAntwerpen - FWO) explains how equipping our white blood cells with a cleverly designed CAR could well help win the race against blood cancer. Want to know more? Fasten your seatbelts & watch the video 🏎

Do you remember Pac-Man, from that old skool computer game? Well, did you know that there are Pac-Mans in every single cell of our body? They're called enzymes. Some of these enzymes work too fast or too slow, and this can cause severe diseases. Michaela Prothiwa (KU Leuven) explains how she wants to track down these malfunctioning enzymes using a clever piece of chemistry.

What if you only had 15 months to live? Hard to imagine, right? Yet every day, around 1,000 people worldwide hear this news. The verdict: glioblastoma, a malignant brain tumor. Yet a small group of patients manages to survive for more than 10 years with such a brain tumor. Brecht Decraene wants to finds out why.

Why do cancer patients relapse despite receiving treatment? This is often due to dormant cancer cells. These cells lie dormant in the body and manage to escape treatment, for example, chemotherapy. Can substances from camel and llama blood provide a breakthrough?